Comment on Truncated IV acetylcysteine treatment duration has potential to safely preserve resources during the COVID-19 pandemic

Anselm Wonga Austin Toxicology Unit and Emergency Department, Victorian Poisons Information Centre, Austin Health, Emergency Physician and Clinical Toxicologist, NHMRC Research Fellow, Heidelberg, Australia;b Department of Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Australia;c Centre for Integrated Critical Care, Melbourne Medical School, University of Melbourne, Melbourne, AustraliaCorrespondence[email protected]

https://orcid.org/0000-0002-6817-7289 View further author information

"Comment on Truncated IV acetylcysteine treatment duration has potential to safely preserve resources during the COVID-19 pandemic." Clinical Toxicology, 59(1), pp. 77–78

Disclosure statement

No conflicts of interest to declare.

Additional information

Funding

AW is supported by an NHMRC Research Fellowship ID 1159907.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Comment on Truncated IV acetylcysteine treatment duration has potential to safely preserve resources during the COVID-19 pandemic

Information for

Open access

Opportunities

Help and information

Comment on Truncated IV acetylcysteine treatment duration has potential to safely preserve resources during the COVID-19 pandemic

Disclosure statement

Additional information

Funding

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature